Matthew 7:25 Inc, doing business as Thrive Pharmacy, is recalling 563 units of Buprexone and Buprenorphine troches (medicated lozenges) because they are subpotent, meaning they contain less of the active medication than intended. The recall affects three specific products: Buprexone Banana cream (6-0.6 mg), Buprenorphine Watermelon (8 mg), and Buprenorphine Black Cherry (2 mg), which were sold in plastic molds with cardboard sleeves. These medications were distributed to patients in Florida between September 2019 and March 2020.
Subpotent medications provide a lower dose than what was prescribed by a physician, which can lead to the return of symptoms or withdrawal for patients relying on these treatments. This issue was identified as a moderate risk by the FDA, as inconsistent dosing of these specific medications can interfere with ongoing medical treatment plans.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.